Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)Hideki Kato, Ichiei Narita, Masaomi Nangaku et al.|Clinical and Experimental Nephrology|2017Cited by 20
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN studyIchiei Narita, Yoshiharu Tsubakihara, Takashi Wada et al.|PLoS ONE|2022Cited by 20
Segmental Resection of the Duodenum for Treating Leiomyosarcoma Associated with von Recklinghausen's Disease: A Case ReportN. Kawano, Terumitsu Hasebe, Munemasa Ryu et al.|Japanese Journal of Clinical Oncology|1995Cited by 15
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in JapanTerumasa Hayashi, Ichiei Narita, Kenichiro Tanabe et al.|Clinical and Experimental Nephrology|2020Cited by 15